Objective To assess the efficacy and safety of the type I interferon receptor antibody,
anifrolumab, in patients with active, biopsy-proven, Class III/IV lupus nephritis. Methods This …

Introduction Systemic lupus erythematosus (SLE) is an autoimmune disorder that affects
almost every organ system and it is treated with immunomodulation and …

Background Bacterial infections of the lung, skin, bloodstream and other tissues are
common in patients with systemic lupus erythematosus (lupus) and are often more severe …

Objectives To evaluate the predictors of serious infection in patients with systemic lupus
erythematosus (SLE). Methods Serious infections were identified in SLE patients in a …

Osteonecrosis (ON) is a complex and multifactorial complication of systemic lupus
erythematosus (SLE). ON is a devastating condition that causes severe pain and …

Objective To examine the time trends in hospitalized infections in patients with systemic
lupus erythematosus (SLE), and the factors associated with health care utilization and in …

Severe acute respiratory syndrome coronavirus (SARS-CoV-2), the virus causing
Coronavirus disease 2019 (COVID-19), has had a huge impact on health services with a …

Background In previous studies, researchers have identified systemic lupus erythematosus
(SLE) as a risk factor for tuberculosis (TB), but data from TB-endemic countries are still …

Objectives SLE is associated with significant mortality, and data from South Asia is limited.
Thus, we analysed the causes and predictors of mortality and hierarchical cluster-based …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by
diverse organ system disabilities, predominantly affecting young females. The clinical …